Summary

Summary

Contract Unique IdentifierDO1.SLCNTR.606156 
Contract referencePROMESECAL-2021-00585 
Contract description:Adquisición de Medicamentos para el Programa de Alto Costo 
Goods 
Contract Start:
18/03/2022 10:10:00 ((UTC-04:00) Georgetown, La Paz, Manaus, San Juan)
 
Contract End:
30/06/2022 16:00:00 ((UTC-04:00) Georgetown, La Paz, Manaus, San Juan)
 
Legally Binding?
 
Contract StateAccepted 

Contracting Company Identification

Contracting Company Identification


Supplier Company Identification

Supplier Company Identification



Object Info

Object Info

DGCP-08-ProcesosExcepcion 
PROMESECAL-MAE-PEUR-2021-0014 
Adquisicion de Medicamentos para el Programa de Alto Costo 
Adquisicion de Medicamentos para el Programa de Alto Costo 
Dirección de planificación y desarrollo  
Doctores Mallen Guerra, SA_EXT_CP001 
GoodsDominicana 
129,915,000 Dominican Pesos 

Financial & Delivery Conditions

Financial & Delivery Conditions

Delivery optionsTransporte incluido 
Contract Start Date
18/03/2022 10:10:00 ((UTC-04:00) Georgetown, La Paz, Manaus, San Juan)
 
Contract End Date
30/06/2022 16:00:00 ((UTC-04:00) Georgetown, La Paz, Manaus, San Juan)
 
Av. Konrad Adenauer, Prolongación Charles de Gaulle, Municipio Santo Domingo Norte OZAMA O METROPOLITANA DO 

Payment Conditions

Payment Conditions

Payment Method 
Invoice Payment Deadline60 days 

Contract Comments

Contract Comments


 
 
 1 
DO1.PCCNTR.1254866 ContractData Container
 1.1  
-
    
Total sin descuentosValor del descuentoTotal ITBISTotal Otros ImpuestosSubtotalTotal
129,915,000.000.000.000.00133,714,200.00129,915,000.00
    
ReferenciaCódigo UNSPSCCuenta presupuestariaDescripciónCantidadUnidadPrecio unitario estimadoPrecio unitarioImporte moneda orig. s/ITBIS% Desc.Descuento moneda originalMonto Gravado (Obras)% ITBISITBIS Moneda Original% Otros ImpuestosOtros impuestos moneda originalPrecio total estimadoValor del precio de respuesta
    
1
51161708 - Dornasa alfa
2.3.4.1.01Atezolizumab 1200 mg/20 ml vial63UD390,000384,00024,192,000.000.0000.000.0024,570,000.0024,192,000.00
    
4
51161708 - Dornasa alfa
2.3.4.1.01Dornasa Alfa 2.5 mg/2.5 ml amp.500UD2,3502,3501,175,000.000.0000.000.001,175,000.001,175,000.00
    
5
51161708 - Dornasa alfa
2.3.4.1.01Emicizumab 30 mg/ 1ml vial250UD110,000110,00027,500,000.000.0000.000.0027,500,000.0027,500,000.00
    
6
51161708 - Dornasa alfa
2.3.4.1.01Emicizumab 105 mg /0.7 ml vial41UD385,000382,00015,662,000.000.0000.000.0015,785,000.0015,662,000.00
    
7
51161708 - Dornasa alfa
2.3.4.1.01Obinutuzumab 1000mg/40 ml vial10UD97,50099,800998,000.000.0000.000.00975,000.00998,000.00
    
8
51161708 - Dornasa alfa
2.3.4.1.01Pertuzumab 420 mg/ 14 ml vial191UD197,000197,00037,627,000.000.0000.000.0037,627,000.0037,627,000.00
    
12
51111717 - Trastuzumab
2.3.4.1.01Trastuzumab 600 mg/ 5 ml vial266UD73,00063,00016,758,000.000.0000.000.0019,418,000.0016,758,000.00
    
14
51111717 - Trastuzumab
2.3.4.1.01Tocilizumab 80 mg/ 4 ml vial870UD7,6606,9006,003,000.000.0000.000.006,664,200.006,003,000.00
 
Contract Document Template

Contract Document Template

DescriptionFile Name
Download
Download
Download
Download

Budget Settings

Budget Settings

Operation
General Source
484,649,100.00 DOP
 DOP
AccountValueAnnual Availability
2.3.4.1.01484,649,100.00  DOP----View
Payment Calendar
IDDescriptionValueMonthYear
1  TRANSFERENCIA484,649,100.00  DOPMarzo2022
Certificate of Appropriation
YearCertificate CodeCertificate VersionCertificate ValueCertificate StateCertificate Link
2022EG1643372645316POfaN334484,649,100.00  DOP
2023EG1643372645316POfaN334484,649,100.00  DOP